BLCO

BLCO

USD

Bausch + Lomb Corporation Common Shares

$15.550+0.080 (0.517%)

Preço em tempo real

Healthcare
Medical Instruments & Supplies
Canadá

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$15.470

Máximo

$15.554

Mínimo

$15.300

Volume

0.81M

Fundamentos da empresa

Capitalização de mercado

5.5B

Setor

Medical Instruments & Supplies

País

Canada

Estatísticas de negociação

Volume médio

0.52M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $10.45Atual $15.550Máximo $20.712

Notícias relacionadas

BusinessWire

Bausch + Lomb to Hold Investor Day on Nov. 13

Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock

Ver mais
Bausch + Lomb to Hold Investor Day on Nov. 13
Analyst Upgrades

Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17

Barclays analyst Matt Miksic maintains Bausch & Lomb with a Equal-Weight and raises the price target from $16 to $17.

Ver mais
Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17

HC Wainwright & Co. analyst Yi Chen maintains Bausch & Lomb with a Buy and raises the price target from $16 to $17.

Ver mais
HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Raises Price Target to $17
Analyst Upgrades

JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16

JP Morgan analyst Robbie Marcus maintains Bausch & Lomb with a Neutral and raises the price target from $13 to $16.

Ver mais
JP Morgan Maintains Neutral on Bausch & Lomb, Raises Price Target to $16
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18

Evercore ISI Group analyst Vijay Kumar maintains Bausch & Lomb with a Outperform and raises the price target from $17 to $18.

Ver mais
Evercore ISI Group Maintains Outperform on Bausch & Lomb, Raises Price Target to $18
Analyst Upgrades

Wells Fargo Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $16

Wells Fargo analyst Larry Biegelsen maintains Bausch & Lomb with a Equal-Weight and raises the price target from $15 to $16.

Analyst Upgrades

Raymond James Reiterates Outperform on Bausch & Lomb, Raises Price Target to $19

Raymond James analyst Gary Nachman reiterates Bausch & Lomb with a Outperform and raises the price target from $18 to $19.

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.